bankruptcy

The bankruptcy proceedings come after OpGen's unsuccessful attempts to sell Curetis and Ares Genetics or their assets.

The company had previously announced it was laying off 35 percent of its workforce, and the Chapter 7 filing follows a consideration for strategic alternatives.

The Tucson, Arizona-based company will operate its business as a “debtor-in-possession” with more than $2.6 million in outstanding principal amount owed to a bank.